316 related articles for article (PubMed ID: 16904828)
41. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
[TBL] [Abstract][Full Text] [Related]
42. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele.
Diaz-Arrastia R; Gong Y; Fair S; Scott KD; Garcia MC; Carlile MC; Agostini MA; Van Ness PC
Arch Neurol; 2003 Jun; 60(6):818-22. PubMed ID: 12810485
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
Jasinska-Myga B; Opala G; Goetz CG; Tustanowski J; Ochudlo S; Gorzkowska A; Tyrpa J
Arch Neurol; 2007 Feb; 64(2):261-5. PubMed ID: 17296843
[TBL] [Abstract][Full Text] [Related]
44. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology.
Pickering-Brown SM; Owen F; Isaacs A; Snowden J; Varma A; Neary D; Furlong R; Daniel SE; Cairns NJ; Mann DM
Exp Neurol; 2000 Jun; 163(2):452-6. PubMed ID: 10833320
[TBL] [Abstract][Full Text] [Related]
45. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
46. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
Lahiri DK; Sambamurti K; Bennett DA
Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
[TBL] [Abstract][Full Text] [Related]
47. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
48. ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy.
Gambardella A; Aguglia U; Chifari R; Labate A; Manna I; Serra P; Romeo N; Sibilia G; Lepiane E; Russa AL; Ventura P; Cittadella R; Sasanelli F; Colosimo E; Leggio U; Zappia M; Quattrone A
Epilepsia; 2005 Jan; 46(1):110-7. PubMed ID: 15660776
[TBL] [Abstract][Full Text] [Related]
49. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.
Brickell KL; Steinbart EJ; Rumbaugh M; Payami H; Schellenberg GD; Van Deerlin V; Yuan W; Bird TD
Arch Neurol; 2006 Sep; 63(9):1307-11. PubMed ID: 16966510
[TBL] [Abstract][Full Text] [Related]
50. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
51. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
[TBL] [Abstract][Full Text] [Related]
52. The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study.
Vefring H; Haugarvoll K; Tysnes OB; Larsen JP; Kurz MW;
Acta Neurol Scand; 2010 Dec; 122(6):438-41. PubMed ID: 20456244
[TBL] [Abstract][Full Text] [Related]
53. Interaction between genes and environment in neurodegenerative diseases.
Elbaz A; Dufouil C; Alpérovitch A
C R Biol; 2007 Apr; 330(4):318-28. PubMed ID: 17502288
[TBL] [Abstract][Full Text] [Related]
54. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
56. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
[TBL] [Abstract][Full Text] [Related]
57. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery.
Silbert BS; Evered LA; Scott DA; Cowie TF
Ann Thorac Surg; 2008 Sep; 86(3):841-7. PubMed ID: 18721571
[TBL] [Abstract][Full Text] [Related]
58. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease.
Tamura H; Kawakami H; Kanamoto T; Kato T; Yokoyama T; Sasaki K; Izumi Y; Matsumoto M; Mishima HK
J Neurol Sci; 2006 Jul; 246(1-2):79-83. PubMed ID: 16564058
[TBL] [Abstract][Full Text] [Related]
59. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
[TBL] [Abstract][Full Text] [Related]
60. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
